SDOH, healthy lifestyle, and life expectancy in adults with CKM syndrome: two cohort studies
Progress in Cardiovascular Diseases · 2026
DOI: 10.1016/j.pcad.2025.11.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Cardiovascular Diseases, 2026. Verfasst von Qiong Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha 410011, China; National Clinical Research Cen…. Hauptthemen laut MEDLINE: Life Expectancy, Healthy Lifestyle, Social Determinants of Health, Metabolic Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the independent and joint associations of social determinants of health (SDOH) and healthy lifestyle factors with life expectancy among adults with cardiovascular-kidney-metabolic (CKM) syndrome. RESEARCH DESIGN AND METHODS: We analyzed two prospective population-based cohorts: the UK Biobank (2006-2010) and the US National Health and Nutrition Examination Survey (NHANES, 1999-2018). Adults with CKM at baseline and complete data on SDOH and lifestyle indicators were included. Cox proportional hazards models were used to estimate mortality risk by CKM stage, SDOH, and lifestyle adherence. Life expectancy at age 50 was calculated using life table methods, stratified by CKM stage and levels of SDOH and lifestyle. RESULTS: A total of 213,738 UK Biobank participants (6.69 % deaths) and 10,345 NHANES participants (9.48 % deaths) were included. Advanced CKM stages were associated with significantly higher mortality risk and shorter life expectancy in both cohorts. Individuals with higher SDOH weighted scores or lower healthy lifestyle scores had elevated mortality risks. The joint effects of poor CKM status, adverse SDOH, and unhealthy lifestyle were additive. In NHANES, life expectancy at age 50 ranged from 33.9 years (CKM stage 0 with healthy lifestyle) to 13.2 years (CKM stage 4 with unhealthy lifestyle). In the UK Biobank, the corresponding figures were 34.2 and 21.7 years. CONCLUSIONS: In two large cohorts, poorer CKM health, greater social disadvantage, and unhealthy lifestyles were each independently and jointly associated with lower life expectancy. These findings support the need for integrated strategies targeting both social and behavioral factors to improve outcomes in CKM populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha 410011, China; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Min…
- Department of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China; Department of Emergency Medicine, Guilin Hospital of the Second Xiangya Hospital, Central South University, Gu…
- Department of Geriatric Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address: hebaimei@csu.edu.cn.
Förderung
- Hunan Provincial Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Huang, Q., Nan, W., He, B., & Peng, Z. (2026). SDOH, healthy lifestyle, and life expectancy in adults with CKM syndrome: two cohort studies. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2025.11.012
Vancouver
Huang Q, Nan W, He B, Peng Z. SDOH, healthy lifestyle, and life expectancy in adults with CKM syndrome: two cohort studies. Progress in Cardiovascular Diseases. 2026. doi:10.1016/j.pcad.2025.11.012
BibTeX
@article{Huang2026,
author = {Huang, Qiong and Nan, Wenbin and He, Baimei and Peng, Zhenyu},
title = {SDOH, healthy lifestyle, and life expectancy in adults with CKM syndrome: two cohort studies},
journal = {Progress in Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.pcad.2025.11.012}
}
EUVIMED